Dapagliflozin Shines in Post-TAVI Patients:DAPA-TAVI Trial Findings Dr. Prem Aggarwal2 July 2025 11:01 AM ISTDapagliflozin reduced the risk of all-cause mortality or worsening heart failure by 28% in patients with aortic stenosis undergoing transcatheter...
State Drug Alert: CDSCO Flags 128 Batches Including Paracetamol, Dapagliflozin Farhat Nasim22 Jun 2025 3:00 PM ISTNew Delhi: As part of its ongoing quality surveillance efforts, the Central Drugs Standard Control Organisation (CDSCO) has flagged more than 120...
Medical Bulletin 20/June/2025 Dr. Bhumika Maikhuri20 Jun 2025 3:00 PM ISTHere are the top medical bulletins for the day:Digital Inhalers May Predict COPD Flare-Ups: Study FindsDigital inhalers may help predict impending...
Clinical Trial Shows Combination Therapy May Benefit Teens with Type 1 Diabetes Dr. Bhumika Maikhuri20 Jun 2025 8:30 AM ISTA clinical trial has found that combining standard insulin therapy with the investigational drug dapagliflozin can improve kidney function, blood...
Windlas Biotech Gets SEC Nod to Manufacture Dapagliflozin-Pioglitazone FDC Parthika Patel17 Jun 2025 6:20 PM ISTNew Delhi: The Subject Expert Committee (SEC) for Endocrinology & Metabolism under the Central Drugs Standard Control Organisation (CDSCO) has...
Zibotentan-Dapagliflozin Combo Shows Promising Results in CKD Patients With and Without Diabetes: Study Medha Baranwal15 Jun 2025 9:15 PM ISTDenmark: A recent post hoc analysis from the ZENITH-CKD trial suggests that combining zibotentan, a selective endothelin receptor antagonist, with...
Dapagliflozin Improves MASH Without worsening liver fibrosis in new Trial Dr. Shravani Dali12 Jun 2025 11:00 AM ISTResearchers have found in a randomized trial in China that dapagliflozin, an SGLT2 inhibitor, improved metabolic dysfunction-associated...
Suspected spurious drugs worth Rs 5.21 lakh seized in Hyderabad Ruchika Sharma6 Jun 2025 5:30 PM ISTTelangana: In a raid conducted at the residence of a habitual offender in Hyderabad, the Drugs Control Administration, Telangana has...
Diabetes drug shows benefits for patients with liver disease: Study Dr. Kamal Kant Kohli5 Jun 2025 5:30 AM ISTThe sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients...
CDSCO Panel Approves BE Study for Alkem's Dapagliflozin, Pioglitazone, Metformin FDC, Seeks Revised Phase III Plan Dr. Divya Colin2 Jun 2025 1:51 PM ISTNew Delhi: Alkem Laboratories has received approval from the Subject Expert Committee (SEC) under the Central Drug Standard Control Organisation...
Justify Sample Size Hike in FDC Trial of Zibotentan-Dapagliflozin, CDSCO Panel Tells AstraZeneca Dr. Divya Colin31 May 2025 6:04 PM ISTNew Delhi: Reviewing the amendment protocol of the AstraZeneca's fixed dose combination (FDC) Zibotentan plus Dapagliflozin, the Subject Expert...
Ajanta Pharma Launches Met-XL D to Improve Outcomes for Heart Failure and Post-Myocardial Infarction Patients Deeksha Bhandari22 May 2025 12:30 PM ISTAjanta Pharma, one of the leaders in the cardiology segment has launched the fixed dose combination of Metoprolol and Dapagliflozin under the brand...
